Factors regulating trophoblast migration and invasiveness: Possible derangements contributing to pre-eclampsia and fetal injury

被引:159
作者
Lala, PK [1 ]
Chakraborty, C
机构
[1] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada
[2] Univ Western Ontario, Dept Pathol, London, ON N6A 5C1, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1016/S0143-4004(03)00063-8
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Impaired trophoblast invasiveness and spiral arterial remodelling, which results in poor placental perfusion during early pregnancy, is believed to cause fetal injury and growth retardation, and also endothelial cell activation/dysfunction in a susceptible mother, leading to clinical manifestations of pre-eclampsia. This article briefly reviews the regulatory roles of certain locally active factors in trophoblast migration and invasiveness. This background is then used to discuss and debate whether derangements or dysfunction of some of these factors can manifest as early serum markers predictive of the disease, as opposed to the intermediate and late stage markers which may reflect manifestations and consequences of the disease. Of particular significance are the observed derangements in uPA/uPAR/PAI system, IGFBP-1, HGF, HB-EGF and TGFbeta, factors which are known to regulate trophoblast migration and invasiveness in situ. An emphasis is placed on the need for longitudinal studies in order to identify predictive serum markers which may help strategies for prevention or amelioration of fetal injury and pre-eclampsia. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:575 / 587
页数:13
相关论文
共 163 条
[81]  
Kupferminc MJ, 1997, AM J REPROD IMMUNOL, V38, P302
[82]   TUMOR-NECROSIS-FACTOR-ALPHA IS ELEVATED IN PLASMA AND AMNIOTIC-FLUID OF PATIENTS WITH SEVERE PREECLAMPSIA [J].
KUPFERMINC, MJ ;
PEACEMAN, AM ;
WIGTON, TR ;
REHNBERG, KA ;
SOCOL, ML .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 170 (06) :1752-1759
[83]   Contemporary concepts of the pathogenesis and management of preeclampsia [J].
Lain, KY ;
Roberts, JM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (24) :3183-3186
[84]   TGFB-responsive human trophoblast-derived cell lines [J].
Lala, PK ;
Graham, CG .
PLACENTA, 2001, 22 (10) :889-890
[85]   Growth factors, proteases and protease inhibitors in the maternal-fetal dialogue [J].
Lala, PK ;
Hamilton, GS .
PLACENTA, 1996, 17 (08) :545-555
[86]  
LALA PK, 1999, TROPHOBLAST RES, V13, P119
[87]   Multiple roles for heparin-binding epidermal growth factor-like growth factor are suggested by its cell-specific expression during the human endometrial cycle and early placentation [J].
Leach, RE ;
Khalifa, R ;
Ramirez, ND ;
Das, SK ;
Wang, J ;
Dey, SK ;
Romero, R ;
Armant, DR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (09) :3355-3363
[88]   Pre-eclampsia and expression of heparin-binding EGF-like growth factor [J].
Leach, RE ;
Romero, R ;
Kim, YM ;
Chaiworapongsa, T ;
Kilbum, B ;
Das, SK ;
Dey, SK ;
Johnson, A ;
Qureshi, F ;
Jacques, S ;
Armant, DR .
LANCET, 2002, 360 (9341) :1215-1219
[89]  
LIBRACH CL, 1994, J BIOL CHEM, V269, P17125
[90]   Fetal and maternal contributions to risk of pre-eclampsia: population based study [J].
Lie, RT ;
Rasmussen, S ;
Brunborg, H ;
Gjessing, HK ;
Lie-Nielsen, E ;
Irgens, LM .
BRITISH MEDICAL JOURNAL, 1998, 316 (7141) :1343-1347